Connect with us

Business Wire

Barnes & Thornburg Adds Expansive Life Sciences Patent Group

Business Wire



Reading Time: 6 minutes

With addition of 17 lawyers and legal professionals, firm opens offices in Research Triangle, two other locations

INDIANAPOLIS–(BUSINESS WIRE)–Barnes & Thornburg has announced the addition of a highly experienced life sciences patent group comprised of 17 lawyers, patent agents, IP technical analysts, and paralegals. With the move, Barnes & Thornburg establishes three new offices in Raleigh, North Carolina, Ann Arbor, Michigan, and Salt Lake City, Utah.

Nine partners, one associate, two patent agents, an IP technical analyst, and four paralegals come to Barnes & Thornburg from the boutique IP firm Brinks, Gilson & Lione. In addition to Raleigh, Ann Arbor, and Salt Lake City, a new member of the Barnes & Thornburg team will be based in Chicago. The group is led by Allen Baum, a respected intellectual property attorney who has been based in Raleigh-Durham for more than 20 years, and William R. Boudreaux, a leading IP attorney in Ann Arbor.

The group brings several decades of combined experience and advanced degrees in such fields as organic chemistry, molecular biology, chemistry and biotechnology. Group members also have in-house experience with some of the foremost names in life sciences and pharmaceuticals and complement the firm’s existing nationally recognized life sciences practice that includes 35 life sciences attorneys, patent agents and legal professionals. The addition of the group continues the firm’s strategic focus on growing its patent practice and overall intellectual property offerings.

“Barnes & Thornburg has a stellar reputation in life sciences and intellectual property, and we are excited to be joining forces with them,” said Baum.

“Bringing in a team of this caliber with their technical backgrounds, strong reputations, combination of client-side and firm experience, and presence across four different markets continues Barnes & Thornburg’s growth story of the past decade,” said Robert T. Grand, firm managing partner. “This latest step expands our geographic footprint, most notably in the booming Raleigh-Durham area, while adding to our already robust life sciences and IP capabilities.”

Expanded Footprint, Trajectory of Growth

The Research Triangle in North Carolina is home to three major research universities and is a leading hub of innovation and patent work. The Raleigh-based team of Baum, Bashir Ali, Amy Fix, Aisha Hasan and Mark Jenkins have practiced in the region for decades – immediately providing Barnes & Thornburg with an established presence in an important market.

The Ann Arbor office, the firm’s third in Michigan, will be staffed by Boudreaux, former in-house counsel at major pharmaceutical companies, and Joshua Ney, a Ph.D. chemist. In July 2019, Barnes & Thornburg opened a Detroit Metro office, bolstering the firm’s Michigan presence that dates back more than 15 years when the Grand Rapids office was established.

Also among the additions are Eric Babych and Ryan Marshall, who will work from Salt Lake City, and Heidi Dare, who joins Barnes & Thornburg’s Chicago office.

“This talented group will further our ability to help clients cultivate and nourish their most valuable innovations,” said Julia Spoor Gard, chair of Barnes & Thornburg’s Intellectual Property Department. “The group is a great cultural fit with our team and their extensive experience in the life sciences sector will strengthen our thriving platform and coast-to-coast reach.”

“We were particularly impressed by Barnes & Thornburg’s growth over the past several years and its great reputation and depth of IP talent,” said Baum. “We’re excited to leverage Barnes & Thornburg’s full-service capabilities – which are increasingly important to clients given the way patent work is now so closely intertwined with regulatory matters and other related areas.”

“In addition to working with larger companies, practicing in the IP space means advising many young and innovative companies, and it’s not long before their success leads to other legal needs,” added Boudreaux. “But regardless of a company’s size, they all want a seamless experience – and we know we’re well positioned to provide that through Barnes & Thornburg’s single-minded dedication to helping businesses achieve their goals with the firm’s broad array of services.”

The Raleigh office will be located at 4819 Emperor Boulevard, Suite 400, Durham, North Carolina 27703. The Ann Arbor office will be located at 2723 South State Street, Suite 150, Ann Arbor, Michigan 48104. The Salt Lake City office will be located at 222 S. Main Street, 5th Floor, Salt Lake City, Utah 84101.

The Team

Allen Baum, who joins as partner-in-charge of the Raleigh office, regularly counsels clients on strategies to protect commercial products, assesses freedom to operate in heavily patented areas and evaluates patents under consideration for licensing, acquisition or investment. He has extensive experience in chemistry, pharmaceuticals, biochemistry, biotechnology and medical devices. Allen also guides clients through post-grant litigation and inter partes review. He is a former president of the Licensing Executives Society (USA and Canada) and former president and chairman of the board of governors for Certified Licensing Professional (CLP).

Bashir M. Ali, who joins as a partner in Raleigh, holds a Ph.D. in chemistry and has worked with companies to obtain hundreds of U.S. patents. He has a deep understanding of complex chemical and pharmaceutical innovations and regularly works to prosecute patents throughout North America, Europe and Asia. He also counsels clients on strategies and prepares opinions on validity, non-infringement and freedom-to-operate issues.

Eric D. Babych, who joins as a partner in Salt Lake City, has deep international experience and has prepared and prosecuted patent applications worldwide. He handles patent appeals before the United States Patent & Trademark Office, Oppositions before the European Patent Office, and he routinely provides guidance on patentability, invalidity, and freedom-to-operate matters. As a former medicinal chemist and inventor, he focuses on the chemical and pharmaceutical arts, although he also has significant experience working with medical devices, consumer products and electronics.

William R. Boudreaux joins as partner in Ann Arbor and serves as attorney-in-charge of the Ann Arbor office. He has spent more than 20 years in private practice and as an in-house counsel, including for major pharmaceutical companies. He counsels biotech and pharmaceutical clients including Fortune 500 companies and has deep experience in global patent portfolio creation and management, pharmaceutical patent life-cycle planning, IP due diligence, freedom-to-operate studies, due diligence reviews, infringement/validity studies, and strategy and support for Hatch-Waxman litigation.

Heidi A. Dare, who joins as a partner in Chicago, has prosecuted over 1,000 patent applications. She focuses on international patent portfolio management and due diligence analyses, with an emphasis on patent prosecution of molecular biology, medical device and medical diagnostics. She has prepared and prosecuted applications related to RNA interference, recombinant nucleic acid and protein technologies, mutational analysis, antibody therapies, transgenic animals and plants, therapeutic vectors, stem cell therapies and gene therapy.

Amy H. Fix, who joins as a partner in Raleigh, has spent approximately two decades representing companies in pharmaceutical, agricultural, and veterinary technologies, and has deep experience with small-molecule drug development. She previously held in-house patent counsel positions with a large, international, pharmaceutical company, as well as an emerging biotech company. She regularly represents clients producing innovative human and animal health drug products to create valuable, worldwide patent portfolios for development assets. Additionally, she counsels her clients through due diligence reviews and collaboration agreements.

Aisha R. Hasan, who joins as an associate in Raleigh, was previously a scientific researcher and focuses her practice on counseling large and small companies on U.S. and foreign patent prosecution, as well as due diligence reviews and complex intellectual property transactions. She regularly works with clients covering a wide breadth of technical areas, including immunotherapies, biotechnology, small-molecule pharmaceuticals, agricultural biotechnology, and diagnostic assays.

Mark Jenkins, who joins as partner in Raleigh, provides clients with guidance on IP strategies and manages both large and small international patent portfolios and applications. Formerly a product development chemist for a global absorbent product design company and analytical chemist for a major healthcare corporation, he now works with companies in sectors such as pharmaceutical, crop science, petroleum additives, polymer, and personal care, and has worked with tissue-banking and biotech companies in the emerging area of regenerative medicine.

Ryan Marshall, who joins as a partner in Salt Lake City, focuses on the pharmaceutical, biotech, chemical and medical device sectors. His clients range from startups to Fortune 50 companies, and he is a regular speaker on intellectual property topics. His experience includes global patent portfolio creation and management, pharmaceutical patent life-cycle planning and IP due diligence, patentability and freedom-to-operate studies, due diligence reviews, infringement/validity studies, and litigation in intellectual property cases.

Joshua E. Ney, who joins as a partner in Ann Arbor, has a Ph.D. in chemistry and is focused on patent litigation and prosecution in the pharmaceutical, biotechnology and chemical industries. He has experience in therapeutic applications, including antiviral therapies, antibiotics, cardiovascular disease, central nervous system disorders, Huntington’s disease, lower urinary tract disorders, menopausal symptoms, osteoarthritis, and pain management. He represents clients regarding new chemical entities, second medical uses, pharmaceutical formulations, synthetic processes and pharmaceutical polymorphs.

With more than 600 attorneys and other legal professionals, Barnes & Thornburg is one of the largest law firms in the country. The firm serves clients worldwide from offices in Atlanta, California, Chicago, Delaware, Indiana, Michigan, Minneapolis, Ohio, Raleigh, Salt Lake City, Texas and Washington, D.C. For more information, visit us online at or on Twitter @BTLawNews.


Karen Smith

Barnes & Thornburg LLP

(317) 231-7378

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

For the last half century, thousands of communications professionals have turned to us to deliver their news to the audiences most important to their business through the sources they trust most. Over that time, we've gone from a single office with one full time employee to more than 500 employees in 32 bureaus.

Business Wire

Shortages of Low-Skill, Middle-Skill, and High-Skill Workers Causing Revenue Declines and Other Headaches for Employers, TrueBlue’s Latest Study Finds

Business Wire



Reading Time: 2 minutes

TACOMA, Wash.–(BUSINESS WIRE)–While there has been a lot of discourse around the shortage of high-skill workers in the U.S., a new study by staffing giant TrueBlue shows a significant percentage of employers are also struggling with deficits in low-skill and middle-skill workers – and dealing with a host of business challenges as a result.

According to TrueBlue’s nationwide survey, which included nearly 1,500 managers (HR, operational, and business), skills shortages are widening across skills categories:

  • 32% of managers can’t find workers to fill low-skill positions (generally classified as those that may or may not require a high school diploma and require little to no experience)
  • 46% can’t find workers for middle-skill jobs (typically require some experience and continuing education such as college courses, an apprenticeship or certification, but don’t necessarily require a four-year college degree)
  • 35% can’t find workers for high-skill jobs (typically require a four-year degree or higher and specialized experience)

Low unemployment coupled with globalization, accelerated technology advancement, and evolving work models are creating talent deficits across all skill levels within organizations,” said Patrick Beharelle, CEO of TrueBlue. “The skills supply is not keeping up with demand, which is fueling a greater intensity in an already competitive labor market and adversely impacting productivity, service quality, and revenue growth for businesses.”

Impact of Talent Shortages on Businesses

The top three business challenges managers are experiencing due to prolonged job vacancies within their organizations include:

  • Quality – More than a third of managers (35%) reported that extended job vacancies have caused lower product or service quality.
  • Turnover – 25% have seen higher employee turnover.
  • Revenue – 23% said their companies experienced a decline in revenue.

To address talent shortages and minimize associated business impact, 2 in 5 companies (41 percent) reported that they plan to raise compensation for entry-level workers and nearly half (46 percent) plan to train and hire the long-term unemployed in the coming year.

Survey Methodology

This SurveyMonkey survey was conducted online in the U.S. by TrueBlue between September 23 and October 15, 2019. It included 1,499 managers (HR, operations and general). The survey was across regions, industries, and company sizes.

About TrueBlue

TrueBlue (NYSE: TBI) is a global leader in specialized workforce solutions that help clients achieve business growth and improve productivity. In 2018, the company connected approximately 730,000 people with work. TrueBlue’s PeopleReady segment offers on-demand industrial staffing services, PeopleManagement offers contingent and productivity-based, on-site industrial staffing and driver staffing services, and PeopleScout offers recruitment process outsourcing (RPO) and managed service provider (MSP) solutions to a wide variety of industries. Learn more at


Jennifer Grasz

Vice President, Corporate Communications
(312) 840-6327

Continue Reading

Business Wire

Law Firm of Estey & Bomberger Reports: Uber Says Nearly 6,000 Rapes, Sexual Assaults Occurred in Two-year Period

Business Wire



Reading Time: < 1 minute

SAN DIEGO–(BUSINESS WIRE)–The law firm of Estey & Bomberger reported today that Uber’s long-awaited sexual assault report was released Dec. 5, with the ride-hailing company admitting that 5,981* passengers and drivers were raped or sexually assaulted between 2017-2018.

“I applaud Uber for releasing the data that acknowledges there is a problem with sexual assaults occurring in rideshare. While we believe these assaults were preventable, Uber’s report represents a tremendous step for ride-hailing safety,” said Estey & Bomberger attorney Mike Bomberger. “I think there are many positive measures Uber is taking. However, Uber still has an obligation to help the victims who have been raped and assaulted and facing a lifetime of emotional pain. They will need ongoing therapy.”

Estey & Bomberger represents more than 100 ride-hailing sexual assault victims.

“It’s important to remember when reading this report that only one in three women report their sexual assault,” Bomberger said. “Therefore, the number of women who have been sexually assaulted is certainly much higher than reported here.”

Bomberger reiterated his call for all ride-hailing trips to be digitally recorded.

“We’re pleased that Uber is now testing cameras in Texas. That’s the real solution to this problem – if drivers know they’re being recorded they won’t rape and assault,” Bomberger said.

Estey & Bomberger is asking Lyft and Uber sexual assault victims, along with former employees of the ride-sharing firms, to contact its office by calling 866-964-1708 or emailing

*statistic courtesy NPR “Uber Received Nearly 6,000 U.S. Sexual Assault Claims in Past 2 Years,” Dec. 5, 2019.


for Estey & Bomberger

Ed Vasquez, 408-420-6558

Continue Reading

Business Wire

Best’s Market Segment Report: AM Best Maintains Global Reinsurance Market Outlook at Stable

Business Wire



Reading Time: 2 minutes

OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has maintained a market segment outlook of stable on the global reinsurance industry for 2020, citing a stabilized pricing environment — albeit at levels below long-term adequacy — the continuing alignment between traditional and third-party capital and ongoing stability in the global life reinsurance segment.

A new Best’s Market Segment Report, titled, “Market Segment Outlook: Global Reinsurance,” states that although rates in the non-life reinsurance market have improved modestly, pricing has not kept adequate pace with the changing risk dynamics, as illustrated by loss development from events such as hurricanes Irma and Maria and Typhoon Jebi, and potential losses from more-recent events (e.g., Hurricane Dorian). Property catastrophe pricing still is being driven by the availability of third-party capital; however, the increasing interdependence between traditional capacity and third-party capital through joint ventures, retrocession and direct ownership should serve to more closely align return objectives for the market overall. Third-party capital also represents a benefit in the form of stabilized earnings of rated balance sheets, due to tail risk being assumed by this capital.

Overall market conditions are improving, but AM Best remains concerned about insufficient rate adequacy relating to certain U.S. casualty lines, a steady decline in the benefit of favorable reserve releases and the pervasive low interest rate environment. The collective effect of these factors requires underwriting discipline, and failure to react to these pressures could adversely affect the segment.

The report outlines other factors that are driving the stable market segment outlook, including:

  • AM Best believes alternative third-party capital will hold the line on future return expectations following the recent heavy catastrophe loss years;
  • A decline in capital consumption and earnings volatility, due in part to the increased utilization of third-party capital in retrocessionaire programs;
  • Greater emphasis on underwriting discipline due to pressure on interest rates and potential slower economic growth globally;
  • Improving pricing momentum driven by higher loss costs, coupled with lower loss reserve redundancies;
  • Increased demand for non-life reinsurance due to primary companies’ recent loss experience, as well as new risk transfer opportunities and mergers and acquisitions;
  • Stable operating performance among life reinsurers, which continue to maintain defensible market positions and offer services beyond risk transfer that create hurdles for new entrants.

To access the full copy of the overall global reinsurance briefing, please visit

Separate briefings on the non-life and life reinsurance segments can be viewed at:

To view a video with AM Best Associate Director Scott Mangan about the global reinsurance market segment outlook, please visit

AM Best is a global credit rating agency, news publisher and data provider specializing in the insurance industry. The company does business in more than 100 countries. Headquartered in Oldwick, NJ, AM Best has offices in cities around the world, including London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit

Copyright © 2019 by A.M. Best Company, Inc. and/or its affiliates.



Robert DeRose
Senior Director
+1 908 439 2200, ext. 5435

Greg Carter
Managing Director
+44 20 7397 0288

Michael Porcelli, FSA
+1 908 439 2200, ext. 5548

Christopher Sharkey
Manager, Public Relations
+1 908 439 2200, ext. 5159

Jim Peavy
Director, Public Relations
+1 908 439 2200, ext. 5644

Continue Reading

Font Resizer

Subscribe to PICANTE via Email

Enter your email address to subscribe to PICANTE and receive notifications of new posts by email.

Follow us on Facebook

Read more from our authors

Follow our Tweets


Please turn AdBlock off